Genetron Holdings Limited (GTH) Financials
GTH Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-03-31 | 142.2 million | 62.2 million |
2022-12-31 | ? | ? |
2022-09-30 | 137.2 million | 60.1 million |
2022-06-30 | 194.7 million | 61.0 million |
GTH Free Cash Flow and Stock based compensation
No data available :(
GTH Net Income
No data available :(
GTH Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-03-31 | 49.4 million | - | - |
2022-12-31 | - | - | - |
2022-09-30 | 47.7 million | - | - |
2022-06-30 | 70.6 million | - | 7.8 million |
GTH Shares Outstanding
GTH Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-03-31 | - | 10.9 million | 11.4 million | 13.0 million |
2022-12-31 | - | - | - | - |
2022-09-30 | - | 10.5 million | 11.0 million | 12.6 million |
2022-06-30 | - | 9.2 million | 9.0 million | 14.1 million |
GTH Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-03-31 | 29.3 million | 17.4 million |
2022-12-31 | - | - |
2022-09-30 | 28.3 million | 16.8 million |
2022-06-30 | 20.6 million | 12.2 million |
GTH
Price: $4.02
52 week price:
Earnings Per Share: -3.67 USD
P/E Ratio: -1.03
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 69849
Market Capitalization: 124.0 million